ANTI-PD-1/CTLA-4 ANTIBODY

Clinical trials for ANTI-PD-1/CTLA-4 ANTIBODY explained in plain language.

Never miss a new study

Get alerted when new ANTI-PD-1/CTLA-4 ANTIBODY trials appear

Sign up with your email to follow new studies for ANTI-PD-1/CTLA-4 ANTIBODY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Double-Punch immunotherapy trial aims to boost survival in tough head and neck cancers

Disease control Recruiting now

This study is testing whether adding a new two-drug immunotherapy (iparomlimab and tuvonralimab) to standard radiation and chemotherapy can better control advanced head and neck cancer. It will involve 27 adults with newly diagnosed, locally advanced cancer who haven't had prior …

Matched conditions: ANTI-PD-1/CTLA-4 ANTIBODY

Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

ANTI-PD-1/CTLA-4 ANTIBODY

Get alerted when new ANTI-PD-1/CTLA-4 ANTIBODY trials appear

Double-Punch immunotherapy trial aims to boost survival in tough head and neck cancers